6-Bromoquinoxaline

CAS: 50998-17-9

Ref. 3D-FB140222

Produktinformation

• Name: 6-Bromoquinoxaline
• Synonyme: Quinoxaline, 6-bromo-

Beschreibung

6-Bromoquinoxaline is a small molecule that inhibits the activity of cyclin-dependent kinases (CDKs) 4 and 6. CDKs are enzymes that regulate the progression of cells through the cell cycle, which is important for cancer prevention. 6-Bromoquinoxaline has been shown to be a potent inhibitor of PD-L1 and pd-L1 expression in vitro and in vivo. This drug is also an antibacterial agent with pharmacophore properties that inhibit bacterial growth by binding to membrane cytochrome c oxidase and catalysing its oxidation. 6-Bromoquinoxaline binds to the type 1 receptor on T cells, leading to death ligand-induced apoptosis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 209.04 g/mol
• Formel: C₈H₅BrN₂
• Reinheit: Min. 95%
• InChl: InChI=1S/C8H5BrN2/c9-6-1-2-7-8(5-6)11-4-3-10-7/h1-5H
• InChI Key: InChIKey=NOYFLUFQGFNMRB-UHFFFAOYSA-N
• SMILES: Brc1ccc2nccnc2c1